Los Angeles, CA -- (SBWire) -- 02/17/2019 --The research study is a compilation of incisive insights about key aspects of the global Inhaled Nitric Oxide market influencing its growth during the course of the forecast period 2019-2025. It shows how the sales of various types of products offered in the global Inhaled Nitric Oxide market are increasing or declining in different regions and countries. The regional study provided in the report includes a brilliant assessment of geographical markets on the basis of factors such as CAGR, market share, production, and consumption. The global Inhaled Nitric Oxide market is segmented in quite some detail for clear explanation of key growth areas that market players can take advantage of.
The global Inhaled Nitric Oxide market is valued at 780 million US$ in 2018 is expected to reach 1490 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025.
Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
Get PDF report template: https://www.qyresearch.com/sample-form/form/965638/global-inhaled-nitric-oxide-forecast-amp%3B-opportunities
The market is highly concentrated, with high technical and professional level. Key vendors in this market are Mallinckrodt, Praxair and Air Liquide, they are taking up to 91.19% market share in 2017. Inhaled Nitric Oxide types commonly used in this market are 800 ppm and 100 ppm, small players tend to produce lower purity products, such as 1000 ppm or so.
According to the research, North America and Europe comprised the biggest consumption areas. Other markets like Japan and China are growing relatively slow.
Though the gross margin is high, but with complex production process and acquisition between enterprises, we tend to believe that this market is going to keep the monopoly status in the forecast period.
This report focuses on Inhaled Nitric Oxide volume and value at global level, regional level and company level. From a global perspective, this report represents overall Inhaled Nitric Oxide market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Mallinckrodt
Praxair
Air Liquide
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
99.92% Purity
99.99% Purity
Other
Segment by Application
ARDS
PPHN
Other Diseases
Access Full Comprehensive Industry Insights (Report USD 2900):
https://www.qyresearch.com/settlement/pre/38a895a3ee35db5dcf245f75fa23bbd4,0,1,Global%20Inhaled%20Nitric%20Oxide%20Forecast%20&%20Opportunities%202019
Highlights of Report
Market definition, product scope, and overview of the global Inhaled Nitric Oxide market
Extensive analysis of market growth, limitations, prospects, risks, and trends
Deep evaluation of market dynamics, including growth drivers, restraints, and opportunities
Comprehensive research on potential changes in sales volume
Competitor analysis with high focus on the business data, product portfolio, market share, and other vital factors that explain the market growth of the players assessed in the report
Special study on changing market dynamics and overall development of the Inhaled Nitric Oxide industry
About QYResearch:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Inhaled Nitric Oxide Market Is Projected to Reach at a 1490 Million USD by the End of 2025, with a CAGR of 8.4%: QY Research
QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.